Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia

Peroxisome proliferator-activated receptor alpha (PPARA) has been suggested as a therapeutic target for chronic lymphocytic leukemia (CLL). However, the underlying molecular mechanism remains largely unclear. In this study, we analyzed DNA next-generation sequencing (NGS) data and clinical informati...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Xixi, Li, Fu, Zhou, Sha, Zeng, Yunjing, Deng, Xiaojuan, Zhang, Hongyang, Li, Jiali, Liu, Hongyun, Rao, Jun, Gao, Lei, Zhang, Cheng, Wen, Qin, Gao, Li, Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317583/
https://www.ncbi.nlm.nih.gov/pubmed/37404899
http://dx.doi.org/10.1155/2023/8456833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317583/
https://www.ncbi.nlm.nih.gov/pubmed/37404899
http://dx.doi.org/10.1155/2023/8456833

Ejemplares similares